Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
M.D. Anderson Cancer Center
Washington University School of Medicine
Queen Mary University of London
OHSU Knight Cancer Institute
QuantumLeap Healthcare Collaborative
The Methodist Hospital Research Institute
University of Colorado, Denver
University of Kentucky
Qilu Hospital of Shandong University
Wake Forest University Health Sciences
Henry Ford Health System
GU Research Network, LLC
University of Virginia
Emory University
Washington University School of Medicine
Cedars-Sinai Medical Center
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Peking University
Royal Marsden NHS Foundation Trust
University of Toledo
Icahn School of Medicine at Mount Sinai
New York Presbyterian Brooklyn Methodist Hospital
University of Chicago
Fox Chase Cancer Center
University of Texas Southwestern Medical Center
University of Florida
Washington University School of Medicine
Sun Yat-sen University
George Washington University
OHSU Knight Cancer Institute
Columbia University
Loyola University
Instituto do Cancer do Estado de São Paulo
University of Arkansas
University of Chicago
Maastricht Radiation Oncology
Jules Bordet Institute
Rigshospitalet, Denmark
Roger Williams Medical Center
Virginia Commonwealth University
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
University of Pittsburgh
Fox Chase Cancer Center
Fox Chase Cancer Center